Literature DB >> 30468452

Association of serum inflammatory markers and diabetic retinopathy: a review of literature.

N S Gouliopoulos1, C Kalogeropoulos, A Lavaris, A Rouvas, I Asproudis, A Garmpi, C Damaskos, N Garmpis, A Kostakis, M M Moschos.   

Abstract

OBJECTIVE: Diabetic retinopathy is the leading cause of irreversible blindness in the western world, among the working-age people. Its exact pathogenesis, however, remains obscure. Systemic inflammation is regarded to play a significant role in diabetes by contributing, among others, to the development of diabetic retinopathy. This review focuses on the possible involvement of the systemic inflammatory markers in the pathogenesis of diabetic retinopathy. PATIENTS AND METHODS: We performed a systematic search of the literature of published papers until August 2017 using the PubMed search engine.
RESULTS: We demonstrated that many systemic inflammatory markers contribute to the pathogenesis and progression of retinopathy, while we highlighted in several occasions their usefulness as a key tool in the monitoring of the disease progression and the treatment efficacy.
CONCLUSIONS: To the best of our knowledge this is the first review in the literature that elaborates the possible association of serum inflammatory markers and diabetic retinopathy, a disease that may cause irreversible loss of vision.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30468452     DOI: 10.26355/eurrev_201811_16243

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Tasquinimod efficacy and S100A9 expression in glucose-treated HREC cells.

Authors:  Ji Jin; Ji Zhang; Shuyang Bu
Journal:  Int Ophthalmol       Date:  2021-11-18       Impact factor: 2.031

2.  Single-cell transcriptomic analysis revealing changes in retinal cell subpopulation levels and the pathways involved in diabetic retinopathy.

Authors:  Rui Zhang; Chengyu Huang; Yixuan Chen; Ting Li; Long Pang
Journal:  Ann Transl Med       Date:  2022-05

3.  Central Macular Thickness in Diabetic Macular Edema.

Authors:  H Gungel; H Aral; F Erdenen; M Gokce; S K Erdur
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

4.  Systemic and vitreous biomarkers - new insights in diabetic retinopathy.

Authors:  Bernardete Pessoa; João Heitor; Constança Coelho; Magdalena Leander; Pedro Menéres; João Figueira; Angelina Meireles; Melo Beirão
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-24       Impact factor: 3.535

5.  Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy.

Authors:  Hui Wang; Hui Lou; Yongrong Li; Fengtao Ji; Wei Chen; Qianyi Lu; Guoxu Xu
Journal:  BMC Ophthalmol       Date:  2020-06-30       Impact factor: 2.209

6.  Diabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes.

Authors:  Stephen H Sinclair; Stanley S Schwartz
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-13       Impact factor: 5.555

Review 7.  Circulating Biomarkers of Inflammation and Endothelial Activation in Diabetic Retinopathy.

Authors:  Federica Storti; Jennifer Pulley; Pascal Kuner; Markus Abt; Ulrich F O Luhmann
Journal:  Transl Vis Sci Technol       Date:  2021-10-04       Impact factor: 3.283

Review 8.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.